Innovator of the Year
Congratulations to the 2023 Innovator or Innovation Team of the Year finalists
Associate Professor Richard Kelso, The University of Adelaide
Associate Professor Richard Kelso’s aerodynamics research has made a significant impact at the highest levels of competitive cycling. His bicycle frame technology, which reduces bicycle drag by up to 10 per cent, has been used by medallists in World Championship and Olympic competitions, and set three world records in 2022.
His bicycle helmet designs use a similar drag-reduction technology and include three of the most successful low-drag helmets ever made.
These innovations have benefited Australian cyclists and teams in national and international competitions and are generating income and recognition for South Australia.
RAH Immuno-Targeted Cancer Therapies
Professor Michael Brown, Associate Professor Lisa Ebert, Dr Tessa Gargett, Dr Alex Staudacher and Dr Vasilios (Bill) Liapis, Central Adelaide Local Health Network
Led by Professor Michael Brown, the RAH Immuno-Targeted Cancer Therapies team has designed, advanced and translated world-first new therapies for brain and pancreatic cancers. These are diseases for which current treatment options are extremely limited. As a result of the team’s focused work over 12 years, new candidate cancer treatments have now progressed to four early-phase clinical trials in patients with solid cancers, including pancreatic and brain cancers.
Immuno-targeted therapies treat cancer through application of technologies based on the science of the immune system. The RAH Immuno-Targeted Cancer Therapies team developed an innovation known as APOMAB-MTR to deliver radiation directly to cancer cells through antibodies, and genetically engineered cells called CAR-T cells that target cancers through a molecule known as GD2.
Commercialisation and clinical expansion for these innovations are now underway or being explored.
The Chrysos PhotonAssay Team
Dr James Tickner, Mr Dirk Treasure, Dr Alvin Chowles and Dr Rhys Preston
Chrysos’ PhotonAssay™ technology replaces centuries-old methods for measuring gold and other valuable metals in mineral ores with a clean, green and super-fast X-ray technology. Whether exploring for new deposits, running a mine or extracting gold, miners need access to rapid, accurate results to manage their operations. PhotonAssay™ not only delivers results in minutes rather than the hours or days required for traditional methods, but it also eliminates health and safety hazards, does away with the production of toxic waste, and halves CO₂ emissions.
Chrysos launched in 2017 to develop and commercialise the PhotonAssay™ technology originally created by the CSIRO. From a modest start with just five employees, Chrysos now employs more than 90 staff on three continents, with half based in its Adelaide headquarters.
With continued growth planned for the years ahead, Chrysos is working to see PhotonAssay™ become the preeminent technology used around the globe for assay of gold, silver, copper and other high-value metals.